Gary Stevenson, co-founder and managing partner of MB Venture Partners. See sector focus and contact routes.
Gary Stevenson, co-founder and managing partner of MB Venture Partners, invests primarily in seed and early-stage medical device and biotechnology companies, with a distinctive thesis focused on product solutions for musculoskeletal diseases. The firm is stage-agnostic but emphasizes early financing, having raised $120–$130 million across four funds with roughly 80% allocated to the musculoskeletal space. Notable portfolio companies include BioMimetic Therapeutics, Cayenne Medical, CrossRoads Extremity Systems, Salient Surgical Technologies, and Spine Wave, all of which were successfully acquired by major strategic buyers like Johnson & Johnson, Medtronic, and Zimmer Biomet.
This profile is part of the StartupFundraising investor database: focus, portfolio history, disclosed location and contact routes, refreshed as new filings and rounds are ingested. Founders use it to check fit before reaching out and to find investors in Memphis.
Investors like Gary Stevenson · Full investor directory · Investor access · Company funding database